Paris-based startup Biomemory has launched new DNA cards that allow owners to store up to one kilobyte of DNA data on a credit card-sized storage device. It works by converting digital information ...

Shakespeare’s entire catalog of sonnets and eight of his tragedies, all of Wikipedia’s English-language pages, and one of the first movies ever made: scientists have been able to fit the contents of ...

Scientists have recently discovered an innovative approach to data storage by harnessing the natural capabilities of DNA. This groundbreaking method promises to revolutionize how we store vast amounts ...

Biomemory SAS, a company that focuses on developing DNA-based data storage devices, today announced it has raised $18 million in an early-stage funding to complete the development of the first ...

SAN FRANCISCO--(BUSINESS WIRE)--Biomemory, the pioneering DNA data storage company, today announced it has raised $18 million in Series A funding. The round was led by Crédit Mutuel Innovation, with ...

Researchers from the Henry and Marilyn Taub Faculty of Computer Science have developed an AI-based method that accelerates DNA-based data retrieval by three orders of magnitude while significantly ...

DNA molecules have long been recognized as green materials with immense potential for high-density and long-term data storage. However, the traditional process of DNA data storage via DNA synthesis ...

Twist Bioscience specializes in synthetic biology and DNA applications, focusing on synthetic DNA, DNA products, and Next-Generation Sequencing tools. The company's revenue-generating segments, ...

With the exponential growth of digital data and the limitations of conventional silicon-based storage and computing technologies, bio-inspired, DNA-driven computing and information storage has emerged ...

Genomika company together with Kaunas University of Technology and other partners, aims to develop an autonomous solution for archiving data in DNA structures According to Renaldas Raišutis, Director ...

DNA data storage is a big deal. Partly, it's because we're based on DNA, and any research into manipulation of that molecule will pay dividends for medicine and biology in general -- but in part, it's ...